US FDA approves Roche’s Evrysdi for use in babies under two months with Spinal Muscular Atrophy EP News Bureau May 31, 2022 Approval based on interim Rainbowfish data which show pre-symptomatic babies treated with Evrysdi for at least one year were able…
